Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
SynKinase
Bafetinib
CHF 0.00
In stock
SYN-1179-M0011 mgCHF 142.00
SYN-1179-M0055 mgCHF 241.00
SYN-1179-M01010 mgCHF 440.00
SYN-1179-M05050 mgCHF 1'334.00
SYN-1179-M100100 mgINQ
| Product Details | |
|---|---|
| Synonyms | NS-187; INNO-406 |
| Product Type | Chemical |
| Properties | |
| Formula | C30H31F3N8O |
| MW | 576.6 |
| CAS | 859212-16-1 |
| Purity Chemicals | ≥95% |
| Appearance | Solid. |
| Solubility | Soluble in DMSO. Slightly soluble (<1mg/ml) in ethanol. |
| Declaration | Manufactured by SynKinase. |
| Other Product Data |
Target: BCR | Kinase Group: PTK | Substrate: Tyrosine Click here for Original Manufacturer Product Datasheet Our product description may differ slightly from the original manufacturers product datasheet. |
| InChi Key | ZGBAJMQHJDFTQJ-DEOSSOPVSA-N |
| Shipping and Handling | |
| Shipping | AMBIENT |
| Short Term Storage | +4°C |
| Long Term Storage | -20°C |
| Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
| Documents | |
| MSDS |
 Download PDF |
| Product Specification Sheet | |
| Datasheet |
Download PDF |
Description
Bafetinib (INNO-406) is a potent and selective dual Bcr-Abl, Lyn inhibitor with IC(50) values of 5.8nM and 19nM, respectively.
Product References
- NS-187, a potent and selective dual Bcr-Abl/Lyn tyrosine kinase inhibitor, is a novel agent for imatinib-resistant leukemia: S. Kimura, et al.; Blood 106, 3948 (2005)
Related Products
